Skip to content
Our Company
Culture and Values
Leadership
Corporate Impact
Environmental, Social, and Governance
Product Donations
Charitable Giving
CME and Research Grants
Careers
Open Roles
Life at Emergent
Locations
Our Focus
Biological Threats
Opioid Crisis
Manufacturing Partnerships
Our Science
Pipeline
Our Products
Product and Medical Inquiries
Latest
Press Releases
Blog
Podcast
Media Statements
Media Resources
Investors
FOLLOW US
Press Releases
November 21, 2006
Emergent BioSolutions Celebrates Initial Public Offering; CEO To Ring Opening Bell on the NYSE
...
Read More
November 15, 2006
Emergent BioSolutions Announces Pricing of Its Initial Public Offering
...
Read More
August 31, 2006
Emergent BioSolutions Awarded Two Grants From NIAID To Support Development Of Anthrax Immune Globulin Therapeutic
...
Read More
August 29, 2006
U.S. Department Of Homeland Security Certifies BioThrax® (Anthrax Vaccine Adsorbed) As An Approved Product For Homeland Security
...
Read More
August 15, 2006
Emergent BioSolutions Inc. Files Registration Statement For Proposed Initial Public Offering
...
Read More
August 3, 2006
Emergent BioSolutions Expands Presence In Germany
...
Read More
July 21, 2006
Cornerstone Ceremony Welcomes New Vaccine Production Facility To Michigan
...
Read More
July 12, 2006
Joe M. Allbaugh, Former FEMA Director, Joins Emergent BioSolutions’ Board Of Directors
...
Read More
June 21, 2006
Former DHHS Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent BioSolutions
...
Read More
June 5, 2006
Emergent BioSolutions Signs Agreement with sanofi pasteur for Development of Novel Meningitis B Vaccine
...
Read More
May 5, 2006
DHHS Expands Emergent BioSolutions’ Contract To Supply BioThrax To The Strategic National Stockpile
...
Read More
February 14, 2006
Emergent BioSolutions Announces Investments In Manufacturing Capability
...
Read More
1
2
…
57
58
59
